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license (http://creativecommons.org/Summary Cryotherapy (or cold treatment) has been a popular treatment to relieve pain
caused by injuries to tissues such as tendons. However, the exact mechanisms behind the
beneficial effects of cryotherapy in tendons remain largely unclear. As prostaglandin E2
(PGE2) is known to be a major mediator of acute inflammation in tissues, which is related
to tissue pain, we hypothesized that the beneficial effects of cryotherapy in tendons are
mediated by downregulation of PGE2 levels. To test this hypothesis, we applied cold
treatment to mouse patellar and Achilles tendons using two animal models: exhaustive
mouse treadmill running and acute mouse tendon injury by needle penetration. We then
measured the levels of PGE2 and protein expression levels of COX-2, an enzyme respon-
sible for PGE2 production in tissues, under both experimental conditions. We found that
treadmill running increased PGE2 levels in both patellar and Achilles tendons compared
to control mice without running. Cold treatment for 30 min after treadmill running was
sufficient to reduce PGE2 levels to near baseline control levels in both tendons. An exten-
sion of cold treatment to 60 min resulted only in a marginal decrease in patellar tendons,
but a marked decrease in Achilles tendons. Moreover, COX-2 protein levels in both ten-
dons were also lowered by cold treatment, suggesting that the reduction of PGE2 levels
in tendons by cold treatment is at least in part due to the decreased COX-2 expression.
Similarly, in the acutely injured tendons, 30 min of cold treatment after needle penetra-
tion reduced PGE2 levels when compared to the controls at room temperature (22
C). This
decrease was sustained up to at least 3 h after the administration of cryotherapy. Givenlogy Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, 210 Lothrop Street,
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76 J. Zhang et al.that PGE2 is a known pain sensitiser, the results of this study suggest that the ability of
cold treatment to reduce pain may be attributable to its ability to decrease PGE2 produc-
tion in tendons.
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Acute injuries to soft tissues such as tendons are some of the
most commonconditions in orthopaedic/sportsmedicine.One
of the popular modalities used to treat these injuries, which
are characterised by swelling, pain, and even haemorrhage, is
cryotherapy, or cold treatment. This therapy is known to have
a wide range of effects on soft tissues, including changing
tissue temperature, blood flow, and metabolism [1]. For
example, cold treatment decreases skeletal blood flow
(thereby reducing swelling) and metabolism in human knees
[2]. In addition, local cold application decreases nerve con-
duction velocities in the extremities [3], which in turn can
reduce muscle spasm and decrease pain sensitivity [3,4]. It is
generally thought that cryotherapy offers benefits to patients
by lowering tissue temperature, which reduces metabolism
and decreases blood flow (microcirculation) and thereby
reduce swelling, which collectively result in alleviating the
pain associated with tissue injury [5,6].
Given that inflammatory responses dominate shortly after
tissue injury, it is possible that cryotherapy may function
through an anti-inflammatory mechanism. In fact, a popular
therapy in athletic settings is whole-body cryotherapy, in
which humans are exposed to extremely cold air (from
110C to140C) in a special cryo-chamber for a very short
period (2 min, in general). Such exposure in rugby players
after an elite rugby training program effectively relieved
pain and inflammatory symptoms by increasing the anti-
inflammatory cytokine interleukin (IL)-10, decreasing proin-
flammatory cytokines (IL-2 and IL-8), and decreasing the
levels of prostaglandin E2 (PGE2) in blood [7]. Localized
cryotherapy has also been shown to reduce inflammation in
specific body parts by decreasing the number of leucocytes
and granulocytes as well as decreasing macrophage infiltra-
tion following soft tissue injury [8]. Except for these and a
few other reports that studied the molecular changes asso-
ciated with the beneficial effects of cryotherapy [7,9,10],
the mechanism of cryotherapy-induced pain reduction in
tendons remains largely unclear.
It is known that pain is associated with the presence of
high levels of inflammatory agents in affected tissues
[11,12]. PGE2 is one such agent; it is produced by inflam-
matory cells (e.g., macrophages) and tendon fibroblasts in
response to tissue injury [13]. PGE2 is a highly active in-
flammatory molecule that causes pain and induces vasodi-
latation [14], hyperalgesia [15], and fever [16].
In general, PGE2 levels are elevated in tissues subjected
to large mechanical loading, such as intense exercise. For
example, high levels of PGE2 were observed in tendon fi-
broblasts subjected to large repetitive mechanical loading
[17]. Recently, we showed a marked increase in PGE2 levels
in tendons and bone marrow in response to a bout of
exhaustive treadmill running [18]. A similar increase in PGE2levels is also observed when tissues are injured, such as in
wounded mouse Achilles tendons [19]. These increases in
PGE2 levels are similar to those observed in tendinopathic
tendons [20], for which cryotherapy has often been recom-
mended to reduce associated pain [9]. Therefore, we
reasoned that the beneficial effects of cold treatment may
be mediated by downregulating PGE2 levels in tendon tis-
sues. To test this hypothesis, we induced high levels of PGE2
production in tendons using two animal models: an exhaus-
tive mouse treadmill running model [18] and an acute mouse
tendon injury model. We then applied cold treatment to the
mice and measured PGE2 production and COX-2 protein
expression in both Achilles and patellar tendons. Our results
show that cold treatment effectively decreases PGE2 levels
and COX-2 expression in both tendons. The findings of this
study explain, at least in part, the mechanism behind cry-
otherapy’s beneficial effects on tendons and justify cry-
otherapy’s wide use in clinical practice.
Materials and methods
We used two animal models to induce high levels of PGE2
production in mouse tendons: (1) mouse treadmill running
model and (2) acute mouse tendon injury model. The
treadmill running protocol, needle penetration procedure,
and subsequent cryotreatment of mice were approved by
the University of Pittsburgh Institutional Animal Care and
Use Committee, Pittsburgh, PA, USA.
Mouse treadmill running model
Twenty-nine C57BL/6J female mice (10 weeks old) were
used in the treadmill running experiment. Twenty-five mice
were allowed to run on the treadmill, whereas four mice
served as controls and were allowed free cage activities.
The treadmill running protocol consisted of training for 1
week with mice running at 13 meters/min for 15 min per
day, followed by one bout of exhaustive running at the
same speed. The longest individual running time was
435 min and the shortest was 193 min. On average, the mice
ran for 313  60 min (mean  SD).
Application of cold treatment after treadmill
running
After treadmill running, cold treatment was applied by sub-
merging the hind legs and feet of mice in treadmill running
groups in a Koolit refrigerant gel (Cold Chain Technologies,
Holliston,MA,USA)maintainedat 8 2C for 30min or 60min.
During cold treatment, the mice were restrained using a
custom-made device to prevent them from moving around.
Control mice remained in cages at room temperature (22C).
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five groups with five mice in each group, which were then
sacrificed at different times. Group TR0 was sacrificed
immediately after treadmill running, along with the control
group (Cont) without treadmill running. Mice in groups TR30
and TR60 were killed after resting in their cages for 30 min
and 60 min, respectively, after treadmill running. Finally,
mice in groups TC30 and TC60 received cold treatment for
30 min and 60 min, respectively, after treadmill running,
and were then sacrificed.
Acute mouse tendon injury model
Forty-five C57BL/6J female mice (8e10 weeks old) were
used in the needle penetration experiment. In each mouse,
both patellar and Achilles tendons were injured separately
by penetration with a needle (26G for patellar and 18G for
Achilles). Based on the treatment received after injury, all
45 mice were divided into nine groups with five mice in
each group. The control group was sacrificed immediately
after needle penetration and was designated as group 0.
Mice in four groups were not given cold treatment but were
allowed to rest after needle penetration at room temper-
ature for 0.5 h, 1.5 h, 2.5 h and 3.5 h and were named
RT0.5, RT1.5, RT2.5, and RT3.5, respectively. Finally, mice
in the last four groups received cold treatment for 30 min
after injury and were allowed to rest in their cages at room
temperature for 0 h, 1 h, 2 h, and 3 h; they were termed as
Groups C0.5, C1.5, C2.5, and C3.5, respectively. In all
groups that received cold treatment or those that rested at
room temperature after injury, the final time lapse from
the point of needle penetration to sacrifice was 0.5 h,
1.5 h, 2.5 h and 3.5 h, respectively.
Application of cold treatment after acute mouse
tendon injury
Similar to treadmill running, cold treatment was applied by
submerging the hind legs and feet of 20 mice in the four
cold treatment groups in a Koolit refrigerant gel (Cold Chain
Technologies) maintained at 8  2C for 30 min followed by
resting for various times from 0 h to 3 h at room tempera-
ture (22C).
Collection of tendon tissues
Immediately after sacrifice, patellar and Achilles tendons
from all mice in the two animal model studies were har-
vested from both hind legs of each mouse. After removing
the paratenons, tendon tissues were weighed and stored in
0.5 ml phosphate buffered saline (PBS) per sample at 20C
until further use.
Measurement of PGE2 in tendons
PGE2 levels in all tendon samples weremeasured according to
the method described previously [21]. In brief, patellar and
Achilles tendon samples fromone leg of eachmouse (nZ 5 for
each type of tendon) in PBS were thawed and centrifuged at
2000g for 30 min at 4C, followed by transfer of the PBS so-
lution from each sample to individual tubes maintained at4C. The tissues were then minced and homogenized in ice-
cold ethyl acetate and centrifuged at 2000g for 30 min at
4C. The supernatant was collected and dried in a stream of
nitrogen gas. Then, the residue was resuspended in the cor-
responding PBS solution previously collected, and either
stored at 80C or used immediately for measurement of
PGE2 levels using a commercially available enzyme linked
immunosorbent assay kit according to the manufacturer’s
instructions (Cat. No. 514010; Cayman Chemical, Ann Arbor,
MI, USA). PGE2 levels in each tendon tissue sample were
normalized to the corresponding tissue weight.
Western blot analysis to determine COX-2
expression
Both patellar and Achilles tendons from the second leg of
eachmouse in the treadmill running groups wereminced and
homogenized using a bullet blender (Next Advance, Averill
Park, NY, USA), followed by protein extraction using a tissue
protein extraction reagent (Cat. No. 78510; Thermo Scien-
tific, Rockford, IL, USA). After the supernatant was collected
by centrifuging at 12,000g for 10min, protein concentrations
were determined by BCA Protein Assay (Pierce, Rockford, IL,
USA). Then, equal amounts of total protein were resolved on
12% SDS-polyacrylamide gels (Bio-Rad, Hercules, CA, USA) at
100 V for 60 min, transferred to nitrocellulose membranes
(Semi-Dry transfer module; Bio-Rad) at 200 mA for 90 min,
blocked in 5% dry milk/TBSeTween 20 (1 h at room temper-
ature), and then probed with rabbit polyclonal anti-COX-2
antibody (1:500 dilution; Cat. No. 4842; Cell Signaling Tech-
nology, Danvers, MA, USA) at room temperature for 5 h. The
membranes were then washed and further incubated with
peroxidase-conjugated goat anti-rabbit antibody (1:2000
dilution in 1% dry milk/PBSeTween 20; Cat. No. SC-2004;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) at room
temperature for 2 h. Finally, an ECL detection kit (Amersham
Biosciences, Piscataway, NJ, USA) was used to detect the
protein bands of interest onX-ray films. Equal protein loading
on the gels was confirmed by stripping the membranes and
reprobing with rabbit monoclonal anti-human GAPDH anti-
body (Cat. No. G8795; Sigma, St. Louis, MO, USA).
Statistical analysis
All data are presented as mean  standard deviation (SD). A
Student t test was used for statistical analysis of the dif-
ference in PGE2 levels between two paired groups (cryo-
treatment and room temperature control groups) at various
time points after cold treatment. The resulting p < 0.05
were considered to indicate statistically significant differ-
ences between cryotreatments and their respective con-
trols at room temperature.
Results
Cold treatment decreased PGE2 levels induced by
mouse treadmill running
The PGE2 level in the patellar tendons of mice immediately
after treadmill running (TR0) was 251.4% higher than the
78 J. Zhang et al.levels in control mice in cages (Cont; Fig. 1A). However,
cold treatments for 30 min (TC30) or 60 min (TC60) after
treadmill running decreased PGE2 levels by 59.7% and
76.1%, respectively, compared to their respective controls
(TR30 and TR60) that remained at room temperature after
treadmill running. Nonetheless, the PGE2 level after 60 min
of cold treatment (TC60) was not significantly different
from the PGE2 level after 30 min of cold treatment (TC30),
with both about 50% lower than the baseline level (Cont;
Fig. 1A).
Compared to mice patellar tendons, the baseline level of
PGE2 (Cont) in Achilles tendons was more than 3-fold higher
(Fig. 1B). Immediately after treadmill running (TR0) the
PGE2 level increased in the tissue by about 75% compared to
cage control mice (Cont). The application of cold treatment
to tendons for 30 min (TC30) decreased PGE2 levels by
33.8%, which was close to the baseline level, whenFigure 1 The effect of cold treatment on prostaglandin E2
(PGE2) levels in the (A) patellar tendon and (B) Achilles tendon
of mice after treadmill running. PGE2 levels in both TC30 and
TC60 groups were lesser than those in the control group (Cont).
There was also no significant difference in PGE2 levels between
groups TC30 and TC60. * Significance at p < 0.05 when
compared to the respective control mice that did not run.
Cont e control mice in cages; TR0 e mice immediately after a
bout of exhaustive treadmill running; TR30 e mice that
remained 30 min at room temperature after treadmill running;
TC30 e mice subjected to cold treatment for 30 min after
treadmill running; TR60 e mice that remained at room tem-
perature for 60 min after treadmill running; TC60 e mice
subjected to cold treatment for 60 min after treadmill running.compared to control mice that remained at room temper-
ature for 30 min after treadmill running (TR30). Cold
treatment for 60 min (TC60) further decreased PGE2 levels
(50.8%) when compared to the group that remained at room
temperature for 60 min (TR60; Fig. 1B).
In contrast to the patellar tendon, reduction in PGE2
level in the Achilles tendon by cold treatment was time-
dependent with PGE2 level in TC60 about 40% lower than
in TC30. Interestingly, in both tendons, 60 min of cold
treatment (TC60) lowered the PGE2 level to about half that
in the corresponding controls (Cont) that did not undergo
treadmill running.
Cold treatment decreased COX-2 expression
elevated by mouse treadmill running
In both patellar and Achilles tendons, COX-2 protein
expression was significantly upregulated as a result of
mouse treadmill running (TR0; Fig. 2A and B). After 30 min
of cold treatment (TC30), COX-2 levels in both tendon types
were markedly reduced to levels below the respective
controls (Cont) and the groups that remained at room
temperature after treadmill running (TR30). These results
corresponded to reduced levels of PGE2 after cold treat-
ment (Fig. 1).
Cold treatment reduced PGE2 levels after acute
tendon injury
Needle penetration into mouse patellar tendon followed by
rest at room temperature increased the levels of PGE2 by
35.2% in the 0.5 h group and 61.5% in the 3.5 h group when
compared to the control group (0 h) that was sacrificed
immediately after injury (Fig. 3A, blue columns). An overall
time-dependent increase in PGE2 levels was noticed after
needle penetration except for a slight decrease at 1.5 h.
However, when mice received cold treatment after injury
by needle penetration, PGE2 levels in the patellar tendon
decreased significantly when compared to the respective
control groups that did not receive the cold treatment.
Immediately after the cold treatment (0.5 h) PGE2 levels
decreased 60.7% when compared to the corresponding
control group that rested at room temperature for 0.5 h;
however, this effect was less pronounced in the groups that
rested for 1 h (50.5%), 2 h (24.2%), and 3 h (49.7%) after
cold treatment (Fig. 3A).
Similar results were observed in the Achilles tendons
that were allowed to rest at room temperature without
cold treatment after needle penetration (Fig. 3B, blue
columns). Consistent with the patellar tendons, the in-
crease in PGE2 levels was proportional to the resting time
after injury i.e., PGE2 levels gradually rose from 18.9% in
the 0.5 h group to a maximum of 50.2% at 2.5 h followed by
a decline to 45.7% in the 3.5 h group. Indeed, cold treat-
ment for 30 min immediately reduced PGE2 levels by 33.5%
in comparison with the corresponding control mice that
rested at room temperature. In contrast to the patellar
tendons, this initial decrease was more pronounced at 1.5 h
(52.4%), 2.5 h (69.3%), and 3.5 h (48.2%) in the Achilles
tendons. These results demonstrate the sustained effect of
cold therapy on acutely injured patellar and Achilles
Figure 2 The effect of cold treatment on COX-2 expression
levels in mouse (A) patellar and (B) Achilles tendons. In both
tendons, treadmill running markedly increased COX-2 levels in
mice (TR0), whereas cold treatment for 30 min (TC30) reduced
COX-2 levels to below both the control group (Cont) and the
group that remained in room temperature after treadmill
running (TR30).
Figure 3 PGE2 levels in the (A) patellar tendon and (B)
Achilles tendon of mice exposed to cold treatment after needle
penetration. Treatment time on the X axis indicates the total
time lapse from needle penetration to tissue harvest. The
treatment time point 0 refers to the group used for PGE2
measurement immediately after needle penetration; red col-
umns refer to groups that received cold treatment for 30 min
and blue columns indicate groups of mice that remained at
room temperature after needle penetration. * Significance at
p < 0.05 in comparison with the respective controls at room
temperature.
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immediately in the patellar tendon and at 2.5 h in the
Achilles tendon. Interestingly, in both types of tendons, the
decrease lasted up to 3 h after cold treatment (Fig. 3B).
Discussion
Using quantitative measurements, we have shown in this
study that cold treatment markedly decreases the high
PGE2 levels induced by exhaustive mouse treadmill running
and needle penetration in both patellar and Achilles ten-
dons of mice. Because PGE2 is a known mediator of pain,
our data suggest that the overall pain relief by cold treat-
ment in patients may be in part attributed to its ability to
decrease PGE2 levels in tendinous tissues.
It is known that PGE2 is synthesised from arachidonic
acid via a series of intermediate steps, including the acti-
vation of COX-2, an enzyme that is necessary for the pro-
duction of PGE2 and other prostanoids [22]. Therefore,
changes in COX-2 expression would be expected to precede
changes in PGE2 levels. Indeed, our data show that high
levels of PGE2 production due to mouse treadmill running
corresponded to high levels of COX-2 expression in both
patellar and Achilles tendons of mice. Cryotherapy, in
contrast, markedly reduced both PGE2 levels and COX-2
expression in patellar and Achilles tendons. Hence, the
increase or decrease in PGE2 levels by treadmill running or
cold treatment could be attributed in part to up- or
downregulation in COX-2 expression, respectively. Indeed,
increased COX-2 expression has been previously reported
in vitro in human patellar tendon fibroblasts exposed to
large-magnitude stretching [23], in rabbit flexor tendons
exposed to continuous static load [24], and in wounded
mouse tendons in vivo [19]. This is also the mechanism bywhich anti-inflammatory drugs such as non-steroidal anti-
inflammatory drugs (NSAIDs) commonly used in clinical
practices relieve pain associated with injurydi.e., by
blocking COX-2 expression/activity and thereby down-
regulating PGE2 levels.
In this study, we observed that 30 min of cold treatment
was adequate to reduce both COX-2 and PGE2 levels in the
tendons to baseline levels or even lower. In clinical prac-
tice, 10e20 min of cryotherapy for injured soft tissues is
recommended [6], which is in line with the findings of this
study that cold treatment for a short duration of 30 min is
sufficient to significantly reduce both COX-2 and PGE2
levels. For complex joints with various tissue components,
however, longer durations (4 h) of cryotherapy seem
appropriate because cryotreatment in the form of Cryo/
Cuff filled with ice water decreased synovial PGE2 levels in
humans after knee arthroscopy [9], demonstrating that the
anti-inflammatory effect of cryotherapy is exerted by
80 J. Zhang et al.reducing the PGE2 levels in tissues. Moreover, our results
indicate the immediate and sustained effects of cold
treatment in mouse patellar and Achilles tendons by
reducing the high levels of PGE2 induced by treadmill
running and needle penetration both immediately after
applying the cold treatment and up to 3 h after the appli-
cation. Beyond this time point, we presume that the anti-
inflammatory effects exerted by a single 30-min bout of
cold treatment may be decreased.
Although we attempted to gain scientific evidence to
justify the use of cryotherapy in the treatment of tendon
injuries, a limitation of mouse treadmill running model is
that it does not cause the type of acute tendon injury for
which cryotherapy is often used in clinical settings. Our
rationale in using this model was to increase PGE2 produc-
tion that allowed us to detect the cryotherapy-induced
reduction in the levels of PGE2 and the upstream COX-2
enzyme, which results in PGE2 production. Additionally,
we wanted to take advantage of the way treadmill running
can induce high levels of PGE2 without causing tissue
swelling and a concomitant increase in other inflammatory
mediators such as IL-1b and TNF-a, both of which can occur
after acute tendon injury. Therefore, this model enables us
to observe the effects of cold treatment alone on COX-2 and
PGE2 levels without the compounding effects of other
proinflammatory agents such as IL-1b, which is known to
upregulate PGE2 [25]. Nevertheless, to verify the findings on
the effects of cold treatment on PGE2 and COX-2 from the
application of the mouse treadmill running model, we also
adopted an acute tendon injury model, which is more clin-
ically relevant. As reported in this study, findings from this
mouse tendon injury model were similar to the treadmill
running model, suggesting a similar mechanism of action by
cold treatment in reducing PGE2 in tendons in both models.
Note that in order to analyze the PGE2 levels in tendi-
nous tissues, we harvested mouse tendons immediately
after the cold treatment of acutely injured tendons.
Therefore, it is possible that tendon tissue swelling due to
tendon injury affected the PGE2 levels after cold treat-
ment. We reason that this potential swelling effect, if it
indeed occurred, would be small. The major influence on
PGE2 should come from the cold treatment, because in the
treadmill running model, no tissue swelling should exist,
but, as shown in this study, cold treatment produced a
marked reduction of PGE2 levels in tendinous tissues.
In this study, we investigated the effects of only two
cold treatment durations (30 min and 60 min) in the
treadmill running model and one duration (30 min) in the
needle penetration model. Additional studies are required
to determine the effects of various treatment durations
and different modes of cold treatment, such as intermit-
tent cold treatment, which is a common protocol used in
clinical settings [26], on PGE2 and COX-2 expression in
tendons with acute injuries. In addition, the relationship
between local surface temperature and expression of in-
flammatory mediators should be investigated. Finally, the
temperature, time, and repetitions of cold treatments
should be optimized for various types of tissue injuries [27].
In summary, this study shows that cold treatment
reduced PGE2 production and COX-2 protein expression in
both patellar and Achilles tendons of mice. Because PGE2 is
involved in tissue inflammation that causes tendon pain, wesuggest that the beneficial effects of cold treatment on
injured tendons is attributable, at least in part, to a
reduction in PGE2 levels, which may result from a decrease
in COX-2 expression levels. Although many NSAIDs targeting
COX-2 are used in clinical settings to reduce pain caused by
tendon injury, the findings of this study justify the appli-
cation of cold treatment as a safe alternative to treat
injured tendons, because cold treatment may also reduce
pain by decreasing the high levels of COX-2 and subsequent
PGE2 production associated with tendon injury. Future
studies should investigate the mode and frequency of cold
treatment on injured tendons to develop an optimal,
evidence-based protocol for treating both acute and
chronic tendon injuries (or tendinopathy).
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